Annual ROE:
141.12%-28.66%(-16.88%)Summary
- As of today, AKBA annual return on equity is 141.12%, with the most recent change of -28.66% (-16.88%) on December 31, 2024.
- During the last 3 years, AKBA annual ROE has risen by +316.49% (+180.47%).
- AKBA annual ROE is now -16.88% below its all-time high of 169.78%, reached on December 31, 2023.
Performance
AKBA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
318.76%+152.11%(+91.28%)Summary
- As of today, AKBA quarterly return on equity is 318.76%, with the most recent change of +152.11% (+91.28%) on June 1, 2025.
- Over the past year, AKBA quarterly ROE has increased by +195.29% (+158.17%).
- AKBA quarterly ROE is now -18.47% below its all-time high of 390.98%, reached on September 30, 2013.
Performance
AKBA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AKBA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -16.9% | +158.2% |
| 3Y3 Years | +180.5% | +286.2% |
| 5Y5 Years | +360.0% | +455.2% |
AKBA ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -16.9% | +159.3% | -2.8% | +125.3% |
| 5Y | 5-Year | -16.9% | +159.3% | -2.8% | +125.3% |
| All-Time | All-Time | -16.9% | +123.4% | -18.5% | +101.1% |
AKBA ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | 318.76%(+91.3%) |
| Mar 2025 | - | 166.65%(-3.6%) |
| Dec 2024 | 141.12%(-16.9%) | 172.88%(+33.4%) |
| Sep 2024 | - | 129.56%(+4.9%) |
| Jun 2024 | - | 123.47%(-11.0%) |
| Mar 2024 | - | 138.74%(-25.7%) |
| Dec 2023 | 169.78%(+171.4%) | 186.84%(-43.0%) |
| Sep 2023 | - | 327.82%(+126.0%) |
| Jun 2023 | - | -1259.94%(-286.4%) |
| Mar 2023 | - | -326.04%(-22.9%) |
| Dec 2022 | -237.83%(-35.6%) | -265.23%(-5.9%) |
| Sep 2022 | - | -250.35%(-46.2%) |
| Jun 2022 | - | -171.21%(+22.0%) |
| Mar 2022 | - | -219.61%(-32.0%) |
| Dec 2021 | -175.37%(-46.9%) | -166.43%(-21.4%) |
| Sep 2021 | - | -137.07%(-21.2%) |
| Jun 2021 | - | -113.10%(+10.8%) |
| Mar 2021 | - | -126.86%(-14.3%) |
| Dec 2020 | -119.39%(-120.0%) | -111.02%(-10.6%) |
| Sep 2020 | - | -100.40%(-11.9%) |
| Jun 2020 | - | -89.74%(-57.0%) |
| Mar 2020 | - | -57.15%(-5.6%) |
| Dec 2019 | -54.27%(-43.3%) | -54.11%(-2.9%) |
| Sep 2019 | - | -52.58%(+1.5%) |
| Jun 2019 | - | -53.37%(+5.3%) |
| Mar 2019 | - | -56.38%(+0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -37.86%(+51.0%) | -56.80%(-21.6%) |
| Sep 2018 | - | -46.71%(+7.8%) |
| Jun 2018 | - | -50.66%(+2.2%) |
| Mar 2018 | - | -51.81%(+46.8%) |
| Dec 2017 | -77.27%(+43.3%) | -97.40%(+45.4%) |
| Sep 2017 | - | -178.29%(+0.9%) |
| Jun 2017 | - | -179.91%(-16.6%) |
| Mar 2017 | - | -154.34%(-36.6%) |
| Dec 2016 | -136.35%(-163.9%) | -112.96%(-30.1%) |
| Sep 2016 | - | -86.81%(-25.1%) |
| Jun 2016 | - | -69.38%(-26.0%) |
| Mar 2016 | - | -55.06%(-13.3%) |
| Dec 2015 | -51.66%(+6.0%) | -48.58%(-15.2%) |
| Sep 2015 | - | -42.17%(-19.8%) |
| Jun 2015 | - | -35.21%(-4.0%) |
| Mar 2015 | - | -33.85%(+81.4%) |
| Dec 2014 | -54.93%(+41.4%) | -182.23%(+12.3%) |
| Sep 2014 | - | -207.72%(+27.6%) |
| Jun 2014 | - | -286.78%(+99.0%) |
| Mar 2014 | - | -28.21K%(>-9900.0%) |
| Dec 2013 | -93.80%(+84.5%) | 12.74%(-96.7%) |
| Sep 2013 | - | 390.98%(+56.2%) |
| Jun 2013 | - | 250.36%(+73.0%) |
| Mar 2013 | - | 144.73%(+19.1%) |
| Dec 2012 | -603.82%(-78.3%) | - |
| Dec 2012 | - | 121.56% |
| Dec 2011 | -338.65% | - |
FAQ
- What is Akebia Therapeutics, Inc. annual return on equity?
- What is the all-time high annual ROE for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual ROE year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly ROE year-on-year change?
What is Akebia Therapeutics, Inc. annual return on equity?
The current annual ROE of AKBA is 141.12%
What is the all-time high annual ROE for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual return on equity is 169.78%
What is Akebia Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, AKBA annual return on equity has changed by -28.66% (-16.88%)
What is Akebia Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of AKBA is 318.76%
What is the all-time high quarterly ROE for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly return on equity is 390.98%
What is Akebia Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, AKBA quarterly return on equity has changed by +195.29% (+158.17%)